Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Chris Packard
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Disorders
Geographic Areas
Sign-in to see full Profile
Network (preview)
32
Shepherd, James
29
Caslake, Muriel
25
Ford, Ian
23
Sattar, Naveed
18
Macfarlane, Peter
16
Cobbe, Stuart
14
Gaw, Allan
13
Buckley, Brendan
13
Stott, David
12
Westendorp, Rudi
12
Jukema, Wouter
11
Blauw, Gerard
11
Murphy, Michael B.
8
Bollen, E L E M
7
de Craen, Anton
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Chris Packard (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sattar Naveed; Murray Heather M; Welsh Paul; Blauw Gerard J; Buckley Brendan M; Cobbe Stuart; de Craen Anton J M; Lowe Gordon D; Jukema J Wouter; Macfarlane Peter W; Murphy Michael B; Stott David J; Westendorp Rudi G J; Shepherd James; Ford Ian; Packard Chris J;
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
PLoS medicine 2009;6(6):e1000099.
-
2009: Sattar N; Murray H M; Welsh P; Blauw G J; Buckley B M; de Craen A J; Ford I; Forouhi N G; Freeman D J; Jukema J W; Macfarlane P W; Murphy M B; Packard C J; Stott D J; Westendorp R G J; Shepherd J;
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly.
Diabetologia 2009;52(2):235-9.
-
2009: Welsh Paul; Murray Heather M; Buckley Brendan M; de Craen Anton J M; Ford Ian; Jukema J Wouter; Macfarlane Peter W; Packard Chris J; Stott David J; Westendorp Rudi G J; Shepherd James; Sattar Naveed
Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population.
Diabetes care 2009;32(2):308-10.
-
2009: Ford Ian; Bezlyak Vladimir; Stott David J; Sattar Naveed; Packard Chris J; Perry Ivan; Buckley Brendan M; Jukema J Wouter; de Craen Anton J M; Westendorp Rudi G J; Shepherd James
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.
PLoS medicine 2009;6(1):e16.
-
2008: Welsh Paul; Packard Chris J; Sattar Naveed
Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
Current opinion in lipidology 2008;19(6):563-71.
-
2008: Barwell N D; Malkova D; Moran C N; Cleland S J; Packard C J; Zammit V A; Gill J M R
Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes.
Diabetologia 2008;51(10):1912-9.
-
2008: Trompet S; de Craen A J M; Slagboom P; Shepherd J; Blauw G J; Murphy M B; Bollen E L E M; Buckley B M; Ford I; Gaw A; Macfarlane P W; Packard C J; Stott D J; Westendorp R G J; Jukema J W;
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.
Experimental gerontology 2008;43(8):801-5.
-
2008: Sattar Naveed; McConnachie Alex; Shaper A Gerald; Blauw Gerard J; Buckley Brendan M; de Craen Anton J; Ford Ian; Forouhi Nita G; Freeman Dilys J; Jukema J Wouter; Lennon Lucy; Macfarlane Peter W; Murphy Michael B; Packard Chris J; Stott David J; Westendorp Rudi G; Whincup Peter H; Shepherd James; Wannamethee S Goya
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies.
Lancet 2008;371(9628):1927-35.
-
2007: Packard Chris J; Westendorp Rudi G J; Stott David J; Caslake Muriel J; Murray Heather M; Shepherd James; Blauw Gerard J; Murphy Michael B; Bollen Edward L E M; Buckley Brendan M; Cobbe Stuart M; Ford Ian; Gaw Allan; Hyland Michael; Jukema J Wouter; Kamper Adriaan M; Macfarlane Peter W; Jolles Jellemer; Perry Ivan J; Sweeney Brian J; Twomey Cillian;
Association between apolipoprotein E4 and cognitive decline in elderly adults.
Journal of the American Geriatrics Society 2007;55(11):1777-85.
-
2007: Ford Ian; Murray Heather; Packard Chris J; Shepherd James; Macfarlane Peter W; Cobbe Stuart M;
Long-term follow-up of the West of Scotland Coronary Prevention Study.
The New England journal of medicine 2007;357(15):1477-86.
-
2007: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Perry Colin G; Sattar Naveed; Packard Chris J; Caslake Muriel J; Petrie John R
Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: heterogeneity of responses.
Atherosclerosis 2007;194(1):134-43.
-
2007: Trompet S; Pons D; DE Craen A J M; Slagboom P; Shepherd J; Blauw G J; Murphy M B; Cobbe S M; Bollen E L E M; Buckley B M; Ford I; Hyland M; Gaw A; Macfarlane P W; Packard C J; Norrie J; Perry I J; Stott D J; Sweeney B J; Twomey C; Westendorp R G J; Jukema J W
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study.
Annals of the New York Academy of Sciences 2007;1100():189-98.
-
2007: Sattar Naveed; McConnachie Alex; Ford Ian; Gaw Allan; Cleland Stephen J; Forouhi Nita G; McFarlane Peter; Shepherd James; Cobbe Stuart; Packard Chris
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.
Diabetes 2007;56(4):984-91.
-
2007: Sattar Naveed; Murray Heather M; McConnachie Alex; Blauw Gerard J; Bollen Edward L E M; Buckley Brendan M; Cobbe Stuart M; Ford Ian; Gaw Allan; Hyland Michael; Jukema J Wouter; Kamper Adriaan M; Macfarlane Peter W; Murphy Michael B; Packard Chris J; Perry Ivan J; Stott David J; Sweeney Brian J; Twomey Cillian; Westendorp Rudi G J; Shepherd James;
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Circulation 2007;115(8):981-9.
-
2006: Packard Chris J
Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease.
Current opinion in lipidology 2006;17(4):412-7.
-
2006: Casas Juan P; Shah Tina; Cooper Jackie; Hawe Emma; McMahon Alex D; Gaffney Dairena; Packard Christopher J; O'Reilly Denis S; Juhan-Vague Irene; Yudkin John S; Tremoli Elena; Margaglione Maurizio; Di Minno Giovanni; Hamsten Anders; Kooistra Teake; Stephens Jeffrey W; Hurel Steven J; Livingstone Shona; Colhoun Helen M; Miller George J; Bautista Leonelo E; Meade Tom; Sattar Naveed; Humphries Steve E; Hingorani Aroon D
Insight into the nature of the CRP-coronary event association using Mendelian randomization.
International journal of epidemiology 2006;35(4):922-31.
-
2006: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Sattar Naveed; Packard Chris J; Petrie John R; Caslake Muriel J
Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men.
Atherosclerosis 2006;185(1):87-96.
-
2005: Packard Chris J; Ford Ian; Robertson Michele; Shepherd James; Blauw Gerard J; Murphy Michael B; Bollen Edward L E M; Buckley Brendan M; Cobbe Stuart M; Gaw Allan; Hyland Michael; Jukema J Wouter; Kamper Adriaan M; Macfarlane Peter W; Perry Ivan J; Stott David J; Sweeney Brian J; Twomey Cillian; Westendorp Rudi G J;
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
Circulation 2005;112(20):3058-65.
-
2005: de Roos Baukje; Caslake Muriel J; Milliner Kevin; Benson G Martin; Suckling Keith E; Packard Chris J
Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
Atherosclerosis 2005;181(1):63-8.
-
2004: Gill Jason M R; Al-Mamari Ali; Ferrell William R; Cleland Stephen J; Packard Chris J; Sattar Naveed; Petrie John R; Caslake Muriel J
Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men.
Journal of the American College of Cardiology 2004;44(12):2375-82.
-
2004: Sattar Naveed; Scherbakova Olga; Ford Ian; O'Reilly Denis St J; Stanley Adrian; Forrest Ewan; Macfarlane Peter W; Packard Chris J; Cobbe Stuart M; Shepherd James;
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.
Diabetes 2004;53(11):2855-60.
-
2004: Shepherd James; Cobbe Stuart M; Ford Ian; Isles Christopher G; Lorimer A Ross; MacFarlane Peter W; McKillop James H; Packard Christopher J;
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995.
Atherosclerosis. Supplements 2004;5(3):91-7.
-
2004: Gill Jason M R; Brown Jacqueline C; Bedford Dorothy; Wright Dawn M; Cooney Josephine; Hughes David A; Packard Chris J; Caslake Muriel J
Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects.
Atherosclerosis 2004;176(1):49-56.
-
2004: Lowe Gordon D O; Rumley Ann; McMahon Alex D; Ford Ian; O'Reilly Denis St J; Packard Christopher J;
Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(8):1529-34.
-
2004: Feeman W E; Sattar Naveed; OReilly Denis St J; Packard Chris J; Shepherd James; Gaw Allan; Macfarlane Peter W; Cobbe Stuart M; Scherbakova Olga; Ford Ian; Haffner Steven M; Isles Chris
Metabolic syndrome and diabetes mellitus.
Circulation 2004;109(3):E23.
-
2004: Packard Chris J; Saito Yasushi
Non-HDL cholesterol as a measure of atherosclerotic risk.
Journal of atherosclerosis and thrombosis 2004;11(1):6-14.
-
2003: Caslake Muriel J; Stewart Grace; Day Stephen P; Daly Elaine; McTaggart Fergus; Chapman M John; Durrington Paul; Laggner Peter; Mackness Michael; Pears John; Packard Chris J
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.
Atherosclerosis 2003;171(2):245-53.
-
2003: Freeman Dilys J; Samani Nilesh J; Wilson Valerie; McMahon Alex D; Braund Peter S; Cheng Suzanne; Caslake Muriel J; Packard Chris J; Gaffney Dairena
A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
European heart journal 2003;24(20):1833-42.
-
2003: Gill Jason M R; Caslake Muriel J; McAllister Craig; Tsofliou Fotini; Ferrell William R; Packard Chris J; Malkova Dalia
Effects of short-term detraining on postprandial metabolism, endothelial function, and inflammation in endurance-trained men: dissociation between changes in triglyceride metabolism and endothelial function. j.gill@bio.gla.ac.uk.
The Journal of clinical endocrinology and metabolism 2003;88(9):4328-35.
-
2003: Kay A D; Day S P; Nicoll J A R; Packard C J; Caslake M J
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.
Atherosclerosis 2003;170(1):141-6.
-
2003: Kay Andrew D; Day Stephen P; Kerr Mary; Nicoll James A R; Packard Chris J; Caslake Muriel J
Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury.
Journal of neurotrauma 2003;20(8):717-23.
-
2003: Caslake Muriel J; Packard Chris J
Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease.
Current opinion in lipidology 2003;14(4):347-52.
-
2003: Sattar Naveed; Gaw Allan; Scherbakova Olga; Ford Ian; O'Reilly Denis St J; Haffner Steven M; Isles Chris; Macfarlane Peter W; Packard Chris J; Cobbe Stuart M; Shepherd James
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
Circulation 2003;108(4):414-9.
-
2003: Gill Jason M R; Brown Jacqueline C; Caslake Muriel J; Wright Dawn M; Cooney Josephine; Bedford Dorothy; Hughes David A; Stanley John C; Packard Chris J
Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL.
The American journal of clinical nutrition 2003;78(1):47-56.
-
2002: Shepherd James; Blauw Gerard J; Murphy Michael B; Bollen Edward L E M; Buckley Brendan M; Cobbe Stuart M; Ford Ian; Gaw Allan; Hyland Michael; Jukema J Wouter; Kamper Adriaan M; Macfarlane Peter W; Meinders A Edo; Norrie John; Packard Chris J; Perry Ivan J; Stott David J; Sweeney Brian J; Twomey Cillian; Westendorp Rudi G J;
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.
Lancet 2002;360(9346):1623-30.
-
2002: Streja Leanne; Packard Chris J; Shepherd James; Cobbe Stuart; Ford Ian;
Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).
The American journal of cardiology 2002;90(7):731-6.
-
2002: Houx P J; Shepherd J; Blauw G-J; Murphy M B; Ford I; Bollen E L; Buckley B; Stott D J; Jukema W; Hyland M; Gaw A; Norrie J; Kamper A M; Perry I J; MacFarlane P W; Meinders A Edo; Sweeney B J; Packard C J; Twomey C; Cobbe S M; Westendorp R G
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk.
Journal of neurology, neurosurgery, and psychiatry 2002;73(4):385-9.
-
2002: Cho Hong Keun; Shin Gilja; Ryu Sung Kee; Jang Yangsoo; Day Stephen P; Stewart Grace; Packard Chris J; Shepherd James; Caslake Muriel J
Regulation of small dense LDL concentration in Korean and Scottish men and women.
Atherosclerosis 2002;164(1):187-93.
-
2002: Forster Lorne F; Stewart Grace; Bedford Dorothy; Stewart James P; Rogers Elizabeth; Shepherd James; Packard Chris J; Caslake Muriel J
Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Atherosclerosis 2002;164(1):129-45.
-
2002: Gaffney Dairena; Pullinger Clive R; O'Reilly Denis St J; Hoffs Michael S; Cameron Isobel; Vass J Keith; Kulkarni Medha V; Kane John P; Schumaker Verne N; Watts Gerald F; Packard Chris J
Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor binding.
Clinica chimica acta; international journal of clinical chemistry 2002;321(1-2):113-21.
-
2002: Freeman Dilys J; Norrie John; Caslake Muriel J; Gaw Allan; Ford Ian; Lowe Gordon D O; O'Reilly Denis St J; Packard Chris J; Sattar Naveed;
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.
Diabetes 2002;51(5):1596-600.
-
2002: Gaffney Dairena; Forster Lorne; Caslake Muriel J; Bedford Dorothy; Stewart J Philip; Stewart Grace; Wieringa Gilbert; Dominiczak Marek; Miller J Paul; Packard Chris J
Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
Atherosclerosis 2002;162(1):33-43.
-
2002: Pirwany Imran R; Sattar Naveed; Greer Ian A; Packard Christopher J; Fleming Richard
Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.
Human reproduction (Oxford, England) 2002;17(3):825-9.
-
2001: Wallace A M; McMahon A D; Packard C J; Kelly A; Shepherd J; Gaw A; Sattar N
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).
Circulation 2001;104(25):3052-6.
-
2001: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria.
Atherosclerosis 2001;157(1):211-20.
-
2001: de Roos B; Caslake M J; Ardern H A; Martin Benson G; Suckling K E; Packard C J
Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia.
Atherosclerosis 2001;156(2):249-54.
-
2001: Pirwany I R; Fleming R; Greer I A; Packard C J; Sattar N
Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Clinical endocrinology 2001;54(4):447-53.
-
2001: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.
Journal of the American Society of Nephrology : JASN 2001;12(2):341-8.
-
2001: Freeman D J; Norrie J; Sattar N; Neely R D; Cobbe S M; Ford I; Isles C; Lorimer A R; Macfarlane P W; McKillop J H; Packard C J; Shepherd J; Gaw A
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.
Circulation 2001;103(3):357-62.
-
2001: de Roos B; Caslake M J; Stalenhoef A F; Bedford D; Demacker P N; Katan M B; Packard C J
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.
The American journal of clinical nutrition 2001;73(1):45-52.
-
2000: Lowe G; Rumley A; Norrie J; Ford I; Shepherd J; Cobbe S; Macfarlane P; Packard C
Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.
Thrombosis and haemostasis 2000;84(4):553-8.
-
2000: Packard C J; O'Reilly D S; Caslake M J; McMahon A D; Ford I; Cooney J; Macphee C H; Suckling K E; Krishna M; Wilkinson F E; Rumley A; Lowe G D
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
The New England journal of medicine 2000;343(16):1148-55.
-
2000: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
Kidney international 2000;58(3):1238-46.
-
2000: Caslake M J; Packard C J; Suckling K E; Holmes S D; Chamberlain P; Macphee C H
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
Atherosclerosis 2000;150(2):413-9.
-
2000: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(5):852-62.
-
2000: Packard C J; Demant T; Stewart J P; Bedford D; Caslake M J; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
Journal of lipid research 2000;41(2):305-18.
-
1999: Ardern H A; Benson G M; Suckling K E; Caslake M J; Shepherd J; Packard C J
Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit.
Journal of lipid research 1999;40(12):2234-43.
-
1999: Shepherd J; Blauw G J; Murphy M B; Cobbe S M; Bollen E L; Buckley B M; Ford I; Jukema J W; Hyland M; Gaw A; Lagaay A M; Perry I J; Macfarlane P W; Meinders A E; Sweeney B J; Packard C J; Westendorp R G; Twomey C; Stott D J
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.
The American journal of cardiology 1999;84(10):1192-7.
-
1999: Packard C J
Apolipoprotein B metabolism in dyslipidaemia and the effect of drugs.
Diabetes, nutrition & metabolism 1999;12(5):311-5.
-
1999: Millar J S; Anber V; Shepherd J; Packard C J
Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions.
Atherosclerosis 1999;145(2):253-60.
-
1999: Packard C J
Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism.
Current opinion in lipidology 1999;10(3):237-44.
-
1999: Pullinger C R; Gaffney D; Gutierrez M M; Malloy M J; Schumaker V N; Packard C J; Kane J P
The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds.
Journal of lipid research 1999;40(2):318-27.
-
1999: Sattar N; Greer I A; Rumley A; Stewart G; Shepherd J; Packard C J; Lowe G D
A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy.
Thrombosis and haemostasis 1999;81(1):71-5.
-
1998: Demant T; Mathes C; Gütlich K; Bedynek A; Steinhauer H B; Bosch T; Packard C J; Warwick G L
A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients.
Kidney international 1998;54(6):2064-80.
-
1998: Freeman D J; Caslake M J; Griffin B A; Hinnie J; Tan C E; Watson T D; Packard C J; Shepherd J
The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma.
European journal of clinical investigation 1998;28(7):584-91.
-
1998: Demant T; Packard C
In vivo studies of VLDL metabolism and LDL heterogeneity.
European heart journal 1998;19 Suppl H():H7-10.
-
1998: Lee W K; Haddad L; Macleod M J; Dorrance A M; Wilson D J; Gaffney D; Dominiczak M H; Packard C J; Day I N; Humphries S E; Dominiczak A F
Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.
Journal of medical genetics 1998;35(7):573-8.
-
1998: Millar J S; Packard C J
Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies.
Current opinion in lipidology 1998;9(3):197-202.
-
1998: Deighan C J; Caslake M J; McConnell M; Boulton-Jones J M; Packard C J
Increased atherogenicity of low-density lipoprotein in heavy proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(5):1183-8.
-
1998: Gaffney D; Hoffs M S; Cameron I M; Stewart G; O'Reilly D S; Packard C J
Influence of polymorphism Q3405E and mutation A3371V in the apolipoprotein B gene on LDL receptor binding.
Atherosclerosis 1998;137(1):167-74.
-
1998: Packard C J
Overview of fenofibrate.
European heart journal 1998;19 Suppl A():A62-5.
-
1997: Packard C J; Shepherd J
Lipoprotein heterogeneity and apolipoprotein B metabolism.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(12):3542-56.
-
1997: Anber V; Millar J S; McConnell M; Shepherd J; Packard C J
Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2507-14.
-
1997: Demant T; Packard C J
Studies of apolipoprotein B-100 metabolism using radiotracers and stable isotopes.
European journal of pediatrics 1997;156 Suppl 1():S75-7.
-
1997: Sattar N; Greer I A; Louden J; Lindsay G; McConnell M; Shepherd J; Packard C J
Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
The Journal of clinical endocrinology and metabolism 1997;82(8):2483-91.
-
1997: MacLeod M J; Lee W K; Devlin A M; Caslake M; Anderson N H; Packard C J; Dominiczak M H; Reid J L; Dominiczak A F
Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemia.
Clinical science (London, England : 1979) 1997;92(3):237-46.
-
1997: Sattar N; Bendomir A; Berry C; Shepherd J; Greer I A; Packard C J
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis.
Obstetrics and gynecology 1997;89(3):403-8.
Sign-in to see more
